Interestingly, we did observe a two-fold increase relative to control in cleaved caspase 3 levels in tumors that had been treated with Hrnr siRNA or AV-951 alone, suggesting that enhanced apoptosis in the tumor may be responsible for the decreased tumor burden we observed in these two groups (Supplementary Fig. 10c, d). This evidence concerns the gene CASP3 and neoplasm.